Latest news:

Ceronco wins Investors Forum

Life sciences sector has confidence in the future in spite of ups and downs
Amsterdam, Wednesday 14 December 2011 – Biotech company Ceronco was awarded the prize for ‘Best Pitch’ at the annual Dutch Life Sciences & Health Conference in Media Plaza in Utrecht yesterday.

» read more

Business Development in Life Sciences

beeld2011A well-planned and well-executed business development strategy is crucial  for growth and expansion in the life sciences industry. Therefore, the central theme of this year’s Dutch Life Sciences & Health Conference will be Business Development. Various aspects of business development will be addressed, such as financing strategies, finding your (first) customer, sales management, deal making and valuation & business modelling.

In addition to an inspiring plenary programme, the conference will feature three interactive sessions discussing drivers for growth in:

•    Medical devices
•    Diagnostics
•    Biopharmaceuticals

The preliminary programme includes keynote lectures by

• Dr. R. (Rudi) Pauwels, Chief Executive Officer Biocartis NV,

• Prof. D. (Désiré) Collen, CEO and Chairman of ThromboGenics,

• Dr. R. (René) Aerts, Vice President Animal Health Global R&D Biologicals MSD Animal Health,

an investors forum, the NGI venture Challenge Award, an information market and networking opportunities.

Presenting companies include Arcarios BV, Biocartis SA, Bioceros BV, IQ+ Medical B.V., MSD Animal Health, MiLabs, NightBalance B.V., Nucletron B.V., Prionics, ProFibrix, Roche Diagnostics, Skyline Diagnostics BV, Synthon BV, ThromboGenics Unitron Group, Utrecht University and Virtual Proteins BV.